Zhengbin Yao
Director, President and CEO · 1 filing · Latest: Feb 2, 2026
ArriVent BioPharma, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
Director, President and CEO · 1 filing · Latest: Feb 2, 2026
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|